171 related articles for article (PubMed ID: 34039301)
1. The effect of loteprednol suspension eye drops after corneal transplantation.
Chen Y; Wang X; Gao M; Gao R; Song L
BMC Ophthalmol; 2021 May; 21(1):234. PubMed ID: 34039301
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of ocular hypertension with the use of topical loteprednol etabonate 0.5% in steroid responders after corneal transplantation.
Holland EJ; Djalilian AR; Sanderson JP
Cornea; 2009 Dec; 28(10):1139-43. PubMed ID: 19770719
[TBL] [Abstract][Full Text] [Related]
3. Loteprednol Etabonate 0.5% Gel Vs. Prednisolone Acetate 1% Solution After Descemet Membrane Endothelial Keratoplasty: Prospective Randomized Trial.
Price MO; Feng MT; Scanameo A; Price FW
Cornea; 2015 Aug; 34(8):853-8. PubMed ID: 26020827
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of a 3-month loteprednol etabonate 0.5% gel taper for routine prophylaxis after photorefractive keratectomy compared to a 3-month prednisolone acetate 1% and fluorometholone 0.1% taper.
Mifflin MD; Betts BS; Frederick PA; Feuerman JM; Fenzl CR; Moshirfar M; Zaugg B
Clin Ophthalmol; 2017; 11():1113-1118. PubMed ID: 28652697
[TBL] [Abstract][Full Text] [Related]
5. Impact of the Topical Ophthalmic Corticosteroid Loteprednol Etabonate on Intraocular Pressure.
Sheppard JD; Comstock TL; Cavet ME
Adv Ther; 2016 Apr; 33(4):532-52. PubMed ID: 26984315
[TBL] [Abstract][Full Text] [Related]
6. Controlled evaluation of loteprednol etabonate and prednisolone acetate in the treatment of acute anterior uveitis. Loteprednol Etabonate US Uveitis Study Group.
Am J Ophthalmol; 1999 May; 127(5):537-44. PubMed ID: 10334346
[TBL] [Abstract][Full Text] [Related]
7. Loteprednol etabonate 0.5% versus prednisolone acetate 1.0% for the treatment of inflammation after cataract surgery.
Lane SS; Holland EJ
J Cataract Refract Surg; 2013 Feb; 39(2):168-73. PubMed ID: 23232255
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Intraocular Pressure, Usage of Topical Steroids, Need for Intraocular Pressure Lowering Drops, and Incidence of Glaucoma Surgery Up to 2 Years After Penetrating Keratoplasty and Endothelial Keratoplasty.
Vu PQ; Aggarwal S; Lu Y; Xie K; Wade M; Bhatt A
J Glaucoma; 2020 Dec; 29(12):1120-1125. PubMed ID: 32826764
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Efficacy of Difluprednate 0.05% and Loteprednol Gel 0.5% After Cataract Surgery.
Abessi B; Brooksby L; Schultze RL
Eye Contact Lens; 2018 Nov; 44 Suppl 2():S37-S42. PubMed ID: 28628490
[TBL] [Abstract][Full Text] [Related]
10. Descemet stripping automated endothelialkeratoplasty (DSAEK) versus repeat penetrating keratoplasty (PKP) to manage eyes with failed corneal graft.
Khairallah A
Ann Saudi Med; 2018; 38(1):36-41. PubMed ID: 29419526
[TBL] [Abstract][Full Text] [Related]
11. Long-term Outcomes on de novo Ocular Hypertensive Response to Topical Corticosteroids After Corneal Transplantation.
Raj A; Salvador-Culla B; Anwar H; Sykakis E; Figueiredo MS; Figueiredo FC
Cornea; 2020 Jan; 39(1):45-51. PubMed ID: 31517723
[TBL] [Abstract][Full Text] [Related]
12. Topical 0.03% tacrolimus preventing rejection in high-risk corneal transplantation: a cohort study.
Magalhaes OA; Marinho DR; Kwitko S
Br J Ophthalmol; 2013 Nov; 97(11):1395-8. PubMed ID: 24008822
[TBL] [Abstract][Full Text] [Related]
13. Comparison of ophthalmic loteprednol etabonate and prednisolone acetate effects on adrenocortical response to ACTH in dogs.
Kline KE; Walton SA; Specht AJ; Santoro D; Watson TJ; Eide ML; Opgenorth TA; Plummer CE
Vet Ophthalmol; 2022 Nov; 25(6):468-475. PubMed ID: 35913421
[TBL] [Abstract][Full Text] [Related]
14. Prospective Assessment of Loteprednol Etabonate 0.25% for Prevention of Immunologic Rejection After Descemet Membrane Endothelial Keratoplasty in Eyes With Fuchs Dystrophy.
Price MO; Feng MT; Gang A; Price FW
Cornea; 2023 Sep; ():. PubMed ID: 37733966
[TBL] [Abstract][Full Text] [Related]
15. [Surgical treatment of keratoglobus: key techniques of bridge-shaped flap penetrating keratoplasty and whole lamellar keratoplasty with corneoscleral limbal].
Cheng J; Zhai HL; Wang JY; Dong YL; Wang S; Cong L; Xie LX
Zhonghua Yan Ke Za Zhi; 2019 Dec; 55(12):916-922. PubMed ID: 31874505
[No Abstract] [Full Text] [Related]
16. Loteprednol etabonate ophthalmic suspension 0.5 %: efficacy and safety for postoperative anti-inflammatory use.
Amon M; Busin M
Int Ophthalmol; 2012 Oct; 32(5):507-17. PubMed ID: 22707339
[TBL] [Abstract][Full Text] [Related]
17. Clinical efficacy of Fluorometholone versus Loteprednol eye drops after photorefractive keratectomy: A triple-blinded randomized controlled trial.
Razmjoo H; Mikaniki M; Peyman A; Mikaniki E; Abounoori M; Pourazizi M
Eur J Ophthalmol; 2023 Jan; 33(1):595-601. PubMed ID: 35656757
[TBL] [Abstract][Full Text] [Related]
18. Change in intraocular pressure during long-term use of loteprednol etabonate.
Novack GD; Howes J; Crockett RS; Sherwood MB
J Glaucoma; 1998 Aug; 7(4):266-9. PubMed ID: 9713785
[TBL] [Abstract][Full Text] [Related]
19. Intraocular pressure elevations with loteprednol etabonate: a retrospective chart review.
Rajpal RK; Digby D; D'Aversa G; Mah F; Hollander DA; Conway T
J Ocul Pharmacol Ther; 2011 Jun; 27(3):305-8. PubMed ID: 21574815
[TBL] [Abstract][Full Text] [Related]
20. Presumed corneal stromal graft rejection after deep anterior lamellar keratoplasty in a patient with systemic lupus erythematosis.
Jhanji V; Agarwal T; Sharma N; Vajpayee RB
Eye Contact Lens; 2010 Nov; 36(6):371-3. PubMed ID: 20935566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
